Tempest Therapeutics, Inc.

TPST ·Healthcare, Drug Manufacturers - General, United States
Financial Statements › SEC Filings

SEC Filings

Form Filed Description
DEFA14A Oct 20, 2026 CURRENT REPORT
8-K Oct 20, 2026 CURRENT REPORT
8-K Oct 19, 2026 CURRENT REPORT
PRE 14A Oct 16, 2026 PRELIMINARY PROXY STATEMENT
D Oct 14, 2026
4 Oct 2, 2026
3 Oct 2, 2026
424B3 Oct 2, 2026 PROSPECTUS
EFFECT Oct 1, 2026
8-K Sep 28, 2026 CURRENT REPORT
S-3 Sep 25, 2026 REGISTRATION STATEMENT
8-K Sep 17, 2026 8-K
DEFA14A Sep 16, 2026 DEFA14A
8-K Sep 16, 2026 8-K
8-K Sep 15, 2026 8-K
424B3 Sep 1, 2026 424B3
EFFECT Aug 31, 2026
CORRESP Aug 27, 2026
UPLOAD Aug 27, 2026
8-K Aug 24, 2026 8-K
S-1 Aug 21, 2026 S-1
DEFA14A Aug 18, 2026 DEFA14A
8-K Aug 18, 2026 8-K
10-Q Aug 13, 2026 10-Q
8-K Aug 13, 2026 8-K
← Newer Page 1 of 42 · 1047 filings Older →